Eledon Pharmaceuticals, Inc. Increase (Decrease) in Accrued Liabilities
Eledon Pharmaceuticals, Inc. (ELDN) reported Increase (Decrease) in Accrued Liabilities of -$246.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2017-05-03
- Eledon Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for the quarter ending 2017-03-31 was -$246.00K.
- Eledon Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for the quarter ending 2016-12-31 was -$3.07M, a 393.12% decline year-over-year.
- Eledon Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for the quarter ending 2016-09-30 was -$513.00K, a 148.17% decline year-over-year.
- Eledon Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for the quarter ending 2016-06-30 was $1.68M, a 221.84% increase year-over-year.
- Eledon Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for fiscal 2016 was -$2.56M, a 273.78% decline from fiscal 2015.
- Eledon Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for fiscal 2015 was $1.48M, a 15.86% increase from fiscal 2014.
- Eledon Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for fiscal 2014 was $1.27M, a 34.11% increase from fiscal 2013.
- Eledon Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for fiscal 2013 was $950.00K, a 1133.77% increase from fiscal 2012.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$246.00K 10-Q · filed 2017-05-03 | -$3.31M derived: sum of 2 quarters · filed 2017-05-03 | -$3.83M derived: sum of 3 quarters · filed 2017-05-03 | -$2.15M derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-12-31 | -$3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$3.58M derived: sum of 2 quarters · filed 2017-03-03 | -$1.90M derived: sum of 3 quarters · filed 2017-03-03 | -$2.56M 10-K · filed 2017-03-03 |
| 2016-09-30 | -$513.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $1.17M derived: sum of 2 quarters · filed 2016-11-03 | $504.00K 10-Q · filed 2016-11-03 | $1.55M derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-06-30 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $1.02M 10-Q · filed 2016-08-04 | $2.06M derived: sum of 3 quarters · filed 2017-05-03 | $3.13M derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-03-31 | -$663.00K 10-Q · filed 2017-05-03 | $384.00K derived: sum of 2 quarters · filed 2017-05-03 | $1.45M derived: sum of 3 quarters · filed 2017-05-03 | $1.97M derived: sum of 4 quarters · filed 2017-05-03 |
| 2015-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $2.11M derived: sum of 2 quarters · filed 2017-03-03 | $2.63M derived: sum of 3 quarters · filed 2017-03-03 | $1.48M 10-K · filed 2017-03-03 |
| 2015-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $1.59M derived: sum of 2 quarters · filed 2016-11-03 | $429.00K 10-Q · filed 2016-11-03 | $1.73M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-06-30 | $522.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$636.00K 10-Q · filed 2016-08-04 | $661.00K derived: sum of 3 quarters · filed 2017-03-03 | $681.00K derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-03-31 | -$1.16M 10-Q · filed 2016-05-10 | $139.00K derived: sum of 2 quarters · filed 2017-03-03 | $159.00K derived: sum of 3 quarters · filed 2017-03-03 | $548.00K derived: sum of 4 quarters · filed 2017-03-03 |
| 2014-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $1.32M derived: sum of 2 quarters · filed 2017-03-03 | $1.71M derived: sum of 3 quarters · filed 2017-03-03 | $1.27M 10-K · filed 2017-03-03 |
| 2014-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $409.00K derived: sum of 2 quarters · filed 2015-11-10 | -$23.00K 10-Q · filed 2015-11-10 | -$487.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $389.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$43.00K 10-Q · filed 2015-08-12 | -$507.00K derived: sum of 3 quarters · filed 2016-03-10 | |
| 2014-03-31 | -$432.00K 10-Q · filed 2015-05-12 | -$896.00K derived: sum of 2 quarters · filed 2016-03-10 | ||
| 2013-12-31 | -$464.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $950.00K 10-K · filed 2016-03-10 | ||
| 2013-09-30 | $1.41M 10-Q · filed 2014-11-13 | |||
| 2012-12-31 | $77.00K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |